Delivery Order SPE2DB22D1202-SPE2DB24FUTY3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clindamycin PH 1% Solution in 60ML units, with a contract value of $5,685.56. This non-competitive delivery order was awarded on September 24, 2025, with an ultimate completion date of September 25, 2025, and is structured as a firm fixed price contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location. This...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the provision of Clindamycin 600mg medication, with a total potential value of $3,398.46 and a period of performance through February 12, 2024. This delivery order is issued under a larger, single-award indefinite delivery contract (IDC) held by...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,563,979,396 units of the pharmaceutical product Clindamycin 600 mg/50 ml-D5W 50 ml. The $1,198.76 contract has a performance period through March 18, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,866.13 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564109642 - CLINDAMYCIN 900 MG/50 ML-D5W 50ML. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with a performance period through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,348.34 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,327,564 units of Clindamycin Phosphate 1% Lotion in 60 mL containers. This order is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,848.65 contract is for the supply of a pharmaceutical product, Clindamycin 900 mg/50 ml-D5W 50 ml. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through December 31, 2025. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,042.56 to AmerisourceBergen Drug Corp for Clindamycin PH 1% Solution in 60ml quantities. The contract is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and was awarded on September 19, 2025. No set-aside designation was used in this competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of a specific pharmaceutical product - Clindamycin 900 mg/50 ml-D5W 50 ml. The contract has a firm fixed price of $3,734.82 and a period of performance through June 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
- The U.S. Defense Logistics Agency has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $6,389.20 firm fixed price delivery order contract to provide 4563616605 - CLINDAMYCIN 900 MG/50 ML-D5W 50ML. This delivery order is issued under Amerisourcebergen Drug Corp's $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical to deliver pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Clindamycin 600 mg/50 mL in dextrose 5% water solution with a firm fixed price ceiling value of $1,045.64. This is a non-set-aside competitive award with an ultimate completion date of December 4, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUTY3Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of a pharmaceutical product, Clindamycin PH 1% Solution 30ML. The contract has a ceiling value of $3,091.30 and an ultimate completion date of March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 3/15/24 |